Showing results (131-140 of 212) with videos related to
Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
A randomized phase I and pharmacological trial of sequences of 1,3-bis(2-chloroethyl)-1-nitrosourea and temozolomide in patients with advanced solid neoplasmsLisa A Hammond, John R Eckardt, John G Kuhn, et al.Journal of Translational Medicine|June 13, 2009
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancerDavid O Azorsa, Irma M Gonzales, Gargi D Basu, et al.Molecular Cancer Therapeutics|February 22, 2019
CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal AdenocarcinomaGargi Maity, Arnab Ghosh, Vijayalaxmi Gupta, et al.BMC Cancer|January 7, 2017
Case report: whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapiesLeah Zhrebker, Irene Cherni, Lara M Gross, et al.Physical Biology|December 1, 2012
Genomic analysis and selected molecular pathways in rare cancersStephen V Liu, Elizabeth Lenkiewicz, Lisa Evers, et al.European Journal of Cancer (Oxford, England : 1990)|September 29, 2014
Phase I dose-escalation studies of SNX-5422, an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumoursJeffrey R Infante, Glen J Weiss, Suzanne Jones, et al.Investigational New Drugs|July 21, 2017
Phase I dose escalation study of NMS-1286937, an orally available Polo-Like Kinase 1 inhibitor, in patients with advanced or metastatic solid tumorsGlen J Weiss, Gayle Jameson, Daniel D Von Hoff, et al.Molecular Cancer Therapeutics|September 4, 2008
Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancerYoganand Balagurunathan, David L Morse, Galen Hostetter, et al.Scientific Reports|September 4, 2020
Dose-response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulinAndres M Arias Lorza, Harshan Ravi, Rohit C Philip, et al.BMC Systems Biology|August 24, 2012
Specification, annotation, visualization and simulation of a large rule-based model for ERBB receptor signalingMatthew S Creamer, Edward C Stites, Meraj Aziz, et al.Pageof 22